Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Metzgeroth

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Der Internist|August 1, 2015
[Iron deficiency anemia and anemia of chronic disorders]G Metzgeroth, J Hastka
Deutsche Medizinische Wochenschrift (1946)|July 31, 2014
[Systemic mastocytosis]G Metzgeroth, J Schwaab, A Reiter
Cytopathology : Official Journal of the British Society for Clinical Cytology|June 19, 2007
Diagnostic accuracy of cytology and immunocytology in carcinomatous effusionsG Metzgeroth, C Kuhn, B Schultheis, et al.
Onkologie|October 16, 2001
[Selective inhibition of tyrosine kinases - a new therapeutic principle in oncology]A Hochhaus, T Lahaye, S Kreil, et al.
European Journal of Haematology|September 3, 2003
Multilobated nuclei in Waldenström' macroglobulinaemiaG Metzgeroth, Ch Sick, O Maywald, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|January 26, 2007
Intestinal-type adenocarcinoma situated in the nasopharynxG Metzgeroth, W Back, B Schultheis, et al.
Annals of Hematology|February 8, 2003
Auer rod-like inclusions in multiple myelomaG Metzgeroth, W Back, O Maywald, et al.
Leukemia|April 26, 2013
Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phaseG Metzgeroth, J Schwaab, D Gosenca, et al.
Leukemia|September 12, 2008
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in GermanyM Rohrbacher, U Berger, A Hochhaus, et al.
Leukemia|August 6, 2011
Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutationG Metzgeroth, P Erben, H Martin, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Der Internist|August 1, 2015
[Iron deficiency anemia and anemia of chronic disorders]G Metzgeroth, J Hastka
Deutsche Medizinische Wochenschrift (1946)|July 31, 2014
[Systemic mastocytosis]G Metzgeroth, J Schwaab, A Reiter
Cytopathology : Official Journal of the British Society for Clinical Cytology|June 19, 2007
Diagnostic accuracy of cytology and immunocytology in carcinomatous effusionsG Metzgeroth, C Kuhn, B Schultheis, et al.
Onkologie|October 16, 2001
[Selective inhibition of tyrosine kinases - a new therapeutic principle in oncology]A Hochhaus, T Lahaye, S Kreil, et al.
European Journal of Haematology|September 3, 2003
Multilobated nuclei in Waldenström' macroglobulinaemiaG Metzgeroth, Ch Sick, O Maywald, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|January 26, 2007
Intestinal-type adenocarcinoma situated in the nasopharynxG Metzgeroth, W Back, B Schultheis, et al.
Annals of Hematology|February 8, 2003
Auer rod-like inclusions in multiple myelomaG Metzgeroth, W Back, O Maywald, et al.
Leukemia|April 26, 2013
Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phaseG Metzgeroth, J Schwaab, D Gosenca, et al.
Leukemia|September 12, 2008
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in GermanyM Rohrbacher, U Berger, A Hochhaus, et al.
Leukemia|August 6, 2011
Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutationG Metzgeroth, P Erben, H Martin, et al.
Pageof 2